Understanding Recent Advances In Targeted Therapies For Tnbc
Let's dive into the details surrounding Recent Advances In Targeted Therapies For Tnbc. Laurence Buisseret, MD, PhD, Institute Jules Bordet, Brussels, Belgium discusses
Key Takeaways about Recent Advances In Targeted Therapies For Tnbc
- Giuseppe Curigliano, MD, PhD, University of Milan, Milan, Italy, provides an update on
- Lisa A. Carey, MD, FASCO, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, shares her thoughts on likely ...
- Harold Burstein, MD, PhD, and Erica Mayer, MD, MPH, discuss the CAPItello-291, VIKTORIA-1, and STX-478 trials which were ...
- ... London, UK gives an outline of
- Aditya Bardia, MBBS, MPH, a breast medical oncologist at Massachusetts General Hospital and Harvard Medical School, ...
Detailed Analysis of Recent Advances In Targeted Therapies For Tnbc
The advent of anti-PD-L1 immunotherapies have significantly improved the Triple-negative breast cancer What are the
Biology and Burden
That wraps up our extensive overview of Recent Advances In Targeted Therapies For Tnbc.
